<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes and evaluation of bronchiectasis in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes and evaluation of bronchiectasis in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Causes and evaluation of bronchiectasis in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Category</td> <td class="subtitle1">Specific examples</td> <td class="subtitle1">Key diagnostic clues<br/> (in addition to a general evaluation)*</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Postinfectious conditions</td> </tr> <tr> <td class="indent1">Protracted bacterial bronchitis</td> <td> <ul> <li>Varied organisms</li> <li>Increased risk of bronchiectasis for recurrent infection (&gt;3 episodes/year) and with <em>Haemophilus influenzae</em></li> </ul> </td> <td> <ul> <li>History of chronic wet cough</li> <li>Sputum culture</li> <li>Response to antibiotics</li> </ul> </td> </tr> <tr> <td class="indent1">Specific pathogens</td> <td> <ul> <li><em>Mycobacterium tuberculosis</em></li> <li>Atypical mycobacteria</li> <li>Fungal infections</li> <li><em>Mycoplasma pneumoniae</em></li> </ul> </td> <td> <ul> <li>History of exposures and characteristic symptoms</li> <li>Serology</li> <li>Sputum cultures</li> </ul> </td> </tr> <tr> <td class="indent1">Severe, chronic, or recurrent bacterial pneumonia</td> <td> <ul> <li>Various organisms, including <em>Staphylococcus aureus</em>, <em>Streptococcus pneumonia</em>, <em>Klebsiella</em>, <em>Pseudomonas aeruginosa</em>, <em>Bordetella pertussis</em></li> </ul> </td> <td> <ul> <li>History of pneumonias</li> <li>Sputum cultures</li> </ul> </td> </tr> <tr> <td class="indent1">Postinfectious bronchiolitis obliterans including unilateral hyperlucent lung (Swyer-James syndrome)</td> <td> <ul> <li>Any lower respiratory viral infections (but particularly adenovirus types 7 and 21), influenza, measles</li> <li><em>M. pneumoniae</em></li> </ul> </td> <td> <ul> <li>History – Often chronic or recurrent cough and wheeze as well as localized inspiratory crackles</li> <li>Chest multidetector CT</li> <li>Previous viral studies (titers, PCR, culture) and serology</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Bronchial narrowing/obstruction</td> </tr> <tr> <td class="indent1">Congenital abnormalities</td> <td> <ul> <li>Airway anomalies (eg, tracheomalacia, bronchomalacia, tracheal or bronchial stenosis, bronchogenic cyst, tracheal bronchus, vascular ring, pulmonary artery aneurysm or dilation)</li> <li>Bronchopulmonary sequestration (intralobar)</li> <li>CPAM (formerly known as CCAM)</li> </ul> </td> <td> <ul> <li>CT scan with angiogram – To evaluate for sequestration, CPAM, vascular slings/rings, or pulmonary artery abnormalities</li> <li>Flexible bronchoscopy – To evaluate for bronchomalacia, ectopic bronchus, bronchial stenosis, or vascular compression</li> </ul> </td> </tr> <tr> <td class="indent1">Foreign body aspiration</td> <td> <ul> <li>Any small objects (eg, nuts, candy, grass seeds)</li> </ul> </td> <td> <ul> <li>History of choking episode even if remote, near-drowning event, and/or recurrent pneumonia</li> <li>Rigid (+/– flexible) bronchoscopy</li> </ul> </td> </tr> <tr> <td class="indent1">Endobronchial obstruction</td> <td> <ul> <li>Mucus plug (postoperative, asthma, middle lobe syndrome)</li> <li>Allergic bronchopulmonary aspergillosis</li> <li>Bronchocentric granulomatosis</li> <li>Endobronchial tumors</li> </ul> </td> <td> <ul> <li>Characteristic findings on chest imaging</li> <li>Serology for <em>Aspergillus</em> IgE</li> <li>Flexible bronchoscopy with BAL, and biopsy in case of bronchocentric granulomatosis</li> </ul> </td> </tr> <tr> <td class="indent1">Hilar adenopathy</td> <td> <ul> <li>Tuberculosis</li> <li>Histoplasmosis</li> <li>Sarcoidosis</li> <li>Tumors</li> </ul> </td> <td> <ul> <li>Chest imaging</li> <li>Serology</li> <li>Flexible bronchoscopy with cultures and biopsy if needed</li> </ul> </td> </tr> <tr> <td class="indent1">External airway compression</td> <td> <ul> <li>Lung masses (eg, tumor, congenital malformations)</li> <li>Severe scoliosis</li> <li>Vascular compression</li> </ul> </td> <td> <ul> <li>Chest imaging</li> <li>Flexible bronchoscopy</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Immunodeficiencies</td> </tr> <tr> <td class="indent1">Immunoglobulin deficiencies</td> <td> <ul> <li>Agammaglobulinemia (<a href="https://www.omim.org/entry/300755" target="_blank">MIM #300755</a>)</li> <li>Hypogammaglobulinemia</li> <li>Specific globulinemia</li> <li>Specific antibody dysfunction</li> <li>Syndromic</li> <li>Common variable immunodeficiency</li> </ul> </td> <td> <ul> <li>Quantitative immunoglobulins</li> <li>Immunoglobulin subclasses</li> <li>Humoral panel with antibody titers to childhood vaccines and pneumococcal vaccine<sup>¶</sup></li> <li>Gene panel for primary immunodeficiency</li> </ul> </td> </tr> <tr> <td class="indent1">Combined immunodeficiencies</td> <td> <ul> <li>Severe combined immunodeficiency (<a href="https://www.omim.org/entry/300400" target="_blank">MIM #300400</a> and others)</li> <li>DiGeorge/velocardiofacial syndrome (<a href="https://www.omim.org/entry/188400" target="_blank">MIM #188400</a>, <a href="https://www.omim.org/entry/192430" target="_blank">MIM #192430</a>)</li> <li>Bare lymphocyte syndrome (T cell receptor defect caused by MHC deficiency; <a href="https://www.omim.org/entry/604571" target="_blank">MIM #604571</a>)</li> <li><em>CXCR4</em> gene mutation (WHIM syndrome, <a href="https://www.omim.org/entry/193670" target="_blank">MIM #193670</a>)</li> <li>CD40 deficiency or CD40 ligand deficiency (hypergammaglobulinemia M syndrome, <a href="https://www.omim.org/entry/606843" target="_blank">MIM #606843</a>, <a href="https://www.omim.org/entry/308230" target="_blank">MIM #308230</a>)</li> <li>Ataxia-telangiectasia (<a href="https://www.omim.org/entry/208900" target="_blank">MIM #208900</a>)</li> <li>Others</li> </ul> </td> <td> <ul> <li>Quantitative immunoglobulins</li> <li>Specific antibody titers</li> <li>Evaluation of lymphocyte subsets (T, B, and NK)</li> <li>Assessment of T cell function</li> <li>Gene panel for primary immunodeficiency</li> </ul> </td> </tr> <tr> <td class="indent1">Leukocyte dysfunction</td> <td> <ul> <li>Chronic granulomatous disease (NADPH oxidase dysfunction; <a href="https://www.omim.org/entry/306400" target="_blank">MIM #306400</a>, others)</li> <li>Leukocyte adhesion deficiency</li> </ul> </td> <td> <ul> <li>DHR test</li> <li>Nitroblue tetrazolium test</li> <li>Genetic testing</li> </ul> </td> </tr> <tr> <td class="indent1">Complement deficiency</td> <td> <ul> <li>C3 deficiency (<a href="https://www.omim.org/entry/613779" target="_blank">MIM #613779</a>), ficolin-3 deficiency (<a href="https://www.omim.org/entry/613860" target="_blank">MIM #613860</a>)</li> </ul> </td> <td> <ul> <li>Complement assays (C3, C4, and THC)</li> <li>Gene panel for primary immunodeficiency</li> </ul> </td> </tr> <tr> <td class="indent1">Acquired immunodeficiencies</td> <td> <ul> <li>Pharmacologic immunosuppression, HIV infection, malnutrition, malignancy, etc</li> </ul> </td> <td> <ul> <li>History of recurrent infections</li> <li>Blood counts</li> <li>HIV testing</li> <li>Quantitative immunoglobulins</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Primary impaired mucociliary clearance</td> </tr> <tr> <td class="indent1">Abnormal secretions</td> <td> <ul> <li>Cystic fibrosis</li> <li>CFTR-related disorder</li> </ul> </td> <td> <ul> <li>Sweat chloride test</li> <li>Genetic testing</li> </ul> </td> </tr> <tr> <td class="indent1">Ciliary dysfunction</td> <td> <ul> <li>Primary ciliary dyskinesia (known as Kartagener syndrome if situs inversus is present)</li> </ul> </td> <td> <ul> <li>Nasal or bronchial ciliary biopsy with motility studies</li> <li>Electron microscopy</li> <li>Genetic testing</li> <li>Imaging to confirm situs inversus in Kartagener syndrome</li> </ul> </td> </tr> <tr> <td class="indent1">Unknown mechanism</td> <td> <ul> <li>Young syndrome (obstructive azoospermia and sinopulmonary disease)</li> </ul> </td> <td> <ul> <li>Sperm count</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Miscellaneous disorders</td> </tr> <tr> <td class="indent1">Aspiration (recurrent, small volume)</td> <td> <ul> <li>Neurologic disorders</li> <li>Vocal cord paralysis</li> <li>Swallowing dysfunction</li> <li>Laryngeal clefts</li> <li>Tracheoesophageal fistula</li> <li>GERD (controversial)<sup>¶</sup></li> </ul> </td> <td> <ul> <li>History of associated disorder or GERD<sup>Δ</sup></li> <li>Feeding evaluation</li> <li>Videofluoroscopic swallow study (modified barium swallow)</li> <li>Fiberoptic endoscopic evaluation of swallowing</li> <li>Direct laryngoscopy with probing for laryngeal cleft</li> </ul> </td> </tr> <tr> <td class="indent1">Ineffective cough with impaired mucus clearance</td> <td> <ul> <li>Muscular dystrophies</li> <li>Other causes (eg, CNS abnormalities and/or muscle weakness)</li> </ul> </td> <td> <ul> <li>Medical history and examination to detect muscle weakness (presents before respiratory dysfunction)</li> <li>Neurologic evaluation</li> </ul> </td> </tr> <tr> <td class="indent1">Systemic autoimmune or inflammatory disorders, or interstitial lung disease</td> <td> <ul> <li>Systemic lupus erythematosus</li> <li>Rheumatoid arthritis</li> <li>Sjögren syndrome</li> <li>Scleroderma</li> <li>Dermatomyositis</li> <li>Relapsing polychondritis</li> <li>Sarcoidosis</li> <li>Inflammatory bowel disease</li> <li>Other causes of interstitial lung disease<sup>◊</sup></li> </ul> </td> <td> <ul> <li>History, physical examination</li> <li>Rheumatologic evaluation</li> <li>Biopsy of affected tissues</li> </ul> </td> </tr> <tr> <td class="indent1">Bronchiolitis obliterans</td> <td> <ul> <li>Post-transplant with chronic rejection (bone marrow, lung transplant)</li> <li>Interstitial lung disease<sup>◊</sup></li> <li>Stevens-Johnson syndrome</li> <li>Other causes</li> </ul> </td> <td> <ul> <li>History   Organ transplant, history of or risk factors for interstitial lung disease<sup>◊</sup> (and distinguish from postinfectious bronchiolitis obliterans above)</li> <li>Chest multidetector CT</li> </ul> </td> </tr> <tr> <td class="indent1">Environmental exposures (inhalation of toxic fumes and dusts)</td> <td> <ul> <li>Smoke, particulate matter</li> <li>Ammonia</li> <li>Nitrogen dioxide</li> <li>Other irritant gases</li> <li>Pneumoconioses (eg, silicate, talc, or coal dust)</li> <li>Lipoid substances</li> </ul> </td> <td> <ul> <li>Exposure history</li> </ul> </td> </tr> <tr> <td class="indent1">Genetic syndromes</td> <td> <ul> <li>Cartilage deficiency (Williams-Campbell syndrome, <a href="https://www.omim.org/entry/211450" target="_blank">MIM 211450</a>)</li> <li>Tracheobronchomegaly (Mounier-Kuhn syndrome)</li> <li>Marfan syndrome (<a href="https://www.omim.org/entry/154700" target="_blank">MIM #154700</a>)</li> <li>Yellow nail syndrome (<a href="https://www.omim.org/entry/153300" target="_blank">MIM %153300</a>)</li> <li>Autosomal dominant polycystic kidney disease (<a href="https://www.omim.org/entry/173900" target="_blank">MIM #173900</a>, <a href="https://www.omim.org/entry/613095" target="_blank">MIM #613095</a>)</li> <li>Alpha-1 antitrypsin deficiency (<a href="https://www.omim.org/entry/613490" target="_blank">MIM #613490</a>)<sup>§</sup></li> <li>Syndromes associated with immune deficiency (refer to above)</li> </ul> </td> <td> <ul> <li>Flexible bronchoscopy</li> <li>Physical examination</li> <li>Family history</li> <li>Possible genetic testing</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>CT: computed tomography; 
        PCR: polymerase chain reaction; 
        CPAM: congenital pulmonary airway malformation; 
        CCAM: congenital cystic adenomatoid malformation; 
        IgE: immunoglobulin E; 
        BAL: bronchoalveolar lavage; 
        MHC: major histocompatibility complex; 
        WHIM: warts, hypogammaglobulinemia, infections, and myelokathexis; 
        NK: natural killer; 
        NADPH: nicotinamide adenine dinucleotide phosphate; 
        DHR: dihydrorhodamine 123; 
        THC: total hemolytic complement (CH50); 
        HIV: human immunodeficiency virus; 
        CFTR: cystic fibrosis transmembrane conductance regulator; 
        GERD: gastroesophageal reflux disease; 
        CNS: central nervous system; 
        PFT: pulmonary function test.</p>
<p>* The general evaluation for bronchiectasis includes a focused history, PFTs (if the child is able), and chest imaging (typically chest radiograph and chest multidetector CT). These steps document bronchiectasis, assess its severity, and may help to identify the specific cause. Additional key diagnostic steps are noted for each category.</p>
<p>¶ If antibody titers are low, administer vaccines and repeat the titers to evaluate the response. Refer to UpToDate content on evaluation of children with recurrent infections.</p>
<p>Δ Although GERD is associated with a modest increase in bronchiectasis risk, its role as a primary cause in children without other risk factors is questionable. If GERD is strongly suspected, the evaluation may include esophageal pH and impedance monitoring and upper gastrointestinal endoscopy. Refer to UpToDate content on evaluation of GERD in children.</p>
<p>◊ Several types of diffuse/interstitial lung disease in children can be complicated by bronchiectasis (often traction bronchiectasis), with or without the histologic finding of bronchiolitis obliterans. Refer to UpToDate content on diffuse/interstitial lung disease in children.</p>
    
    § Pulmonary manifestations of alpha-1 antitrypsin deficiency (emphysema and/or bronchiectasis) generally do not present until mid-adulthood.</div><div id="graphicVersion">Graphic 87712 Version 12.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
